Objective measurement of the alertness level in dementia

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 4, 2003, Pages 212-217

  Edman, Åke ^a   Brunovsky, Martin ^b   Sjögren, Magnus ^a   Wallin, Anders ^a   Matousek, Milos ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alertness; Dementia; EEG; Regional brain syndromes

Indexed keywords

ADULT; AGED; ALERTNESS; ANALYTIC METHOD; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOANALYSIS; CONTROLLED STUDY; DEMENTIA; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; PRIORITY JOURNAL; SLOW BRAIN WAVE;

AGED; AGED, 80 AND OVER; AROUSAL; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; DEMENTIA; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 0346035748     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068782     Document Type: Article

References (38)

1. Edman Å, Matousek M, Wallin A: EEG findings in dementia are related to the parietal lobe syndrome. Dementia 1995;6:323-329.
2. Wallin A, Edman Å, Blennow K, Gottfries CG, Karlsson I, Regland B, Sjögren M: Stepwise comparative status analysis (STEP): A tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 1996;9:185-199.
3. Berger H: Über das Elektrenkephalogramm des Menschen: Fünfte Mitteilung. Arch Psychiatr Nervenkr 1932;98:231-254.
4. Obrist WD, Henry CE: Electroencephalographic frequency analysis of aged psychiatric patients. Electroencephalogr Clin Neurophysiol 1958;10:156-162.
5. Soininen H, Partanen VJ, Helkala EL, Riekkinen PJ: EEG findings in senile dementia and normal aging. Acta Neurol Scand 1982;65:59-70.
6. Saletu B, Anderer P, Paulus E, Grunberger J, Wicke L, Neuhold A, Fischhof PK, Litschauer G: EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alzheimer Dis Assoc Disord 1991;5(suppl 1):S57-S75.
7. Rosén I: Electroencephalography as a diagnostic tool in dementia; a review. Acta Neurol Scand Suppl 1996;168:63-70.
8. Jelic V: Early Diagnosis of Alzheimer's Disease. Focus on Quantitative EEG in Relation to Genetic, Biochemical and Neuroimaging Markers. PhD Diss, Karolinska Institutet, Stockholm, 1999.
9. Knott V, Mohr E, Mahoney C, Ilivitsky V: Quantitative electroencephalography in Alzheimer's disease: Comparison with a control group, population norms and mental status. J Psychiatry Neurosci 2001;26:106-116.
10. Nyström C, Matousek M, Hällström T: Relationships between EEG and biochemical parameters in major depressive disorder. Acta Psychiatr Scand 1988;77:457-462.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 (revised). Washington, American Psychiatric Association, 1987.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stelan M: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-944.
13. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
14. Wallin A, Blennow K: The clinical diagnosis of vascular dementia. Dementia 1994;5:181-184.
15. Wallin A, Blennow K: Clinical subgroups of the Alzheimer syndrome. Acta Neurol Scand 1996; 193(suppl 65):51-57.
16. Brun A, Englund E, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
17. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
18. Bråne G: The GBS Scale - A Geriatric Rating Scale - and its Clinical Application. PhD Diss, Göteborg University, 1989.
19. Edman Å, Matousek M, Sjögren M, Wallin A: Longitudinal EEG findings in dementia related to the parietal brain syndrome and the degree of dementia. Dement Geriatr Cogn Disord 1998;9:199-204.
20. Rinder L, Roupe S, Steen B, Svanborg A: Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. 1. General presentation of the study. Acta Med Scand 1975;198:397-407.
21. Landahl S, Jagenburg R, Svanborg A: Blood components in a 70-year-old population. Clin Chem Acta 1981;112:301-314.
22. Dement WC, Kleitman N: Cyclic variations in EEG during sleep and their relation to eye movements, body motility and dreaming. Electroencephalogr Clin Neurophysiol 1957;9:673-690.
23. Vitiello MV, Poceta JS, Prinz PN: Sleep in Alzheimer's disease and other dementing disorders. Can J Psychol 1991;45:221-239.
24. Moe KE, Vitiello MV, Larsen LH, Prinz PN: Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: Relationships with cognition and function. J Sleep Res 1995;4:15-20.
25. Hess CW: Sleep disorders and dementia (in German). Schweiz Rundsch Med Prax 1997;86:1343-1349.
26. Ancoli-Israel S, Klauber MR, Gillin JC, Campbell SS, Hofstetter CR: Sleep in non-institutionalized Alzheimer's disease patients. Aging 1994;6:451-458.
27. Vitiello MV: Effective treatment of sleep disturbances in older adults. Clin Cornerstone 2000;2:16-27.
28. Rebok GW, Rovner BW, Folstein MF: Sleep disturbance and Alzheimer's disease: Relationship to behavioral problems. Aging 1991;3:193-196.
29. van Someren EJ, Mirmiran M, Swaab DF: Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: Chronobiological perspectives. Behav Brain Res 1993;57:235-253.
30. Vitiello MV, Borson S: Sleep disturbances in patients with Alzheimer's disease: Epidemiology, pathophysiology and treatment. CNS Drugs 2001;15:777-796.
31. Matousek M, Blomstrand C, Wikkelsö C: Automatic EEG analysis in the diagnosis and treatment of organic psychosyndrome due to brain atrophy and normotensive hydrocephalus. Adv Biol Psych 1982;9:8-12.
32. Matousek M: The role of alertness in organic brain syndromes. Sleep 1988;11:47-53.
33. Sheridan PH, Sato S, Forster N, Bruno G, Cox C, Fedio P, Chase TN: Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positronemission tomography and psychometry. Neurology 1988;38:747-750.
34. Riemann D, Lis S, Fritsch-Montero R, Meier T, Krieger S, Hohagen F, Berger M: Effect of tetrahydroaminoacridine on sleep in healthy subjects. Biol Psychiatry 1996;39:796-802.
35. Deurveilher S, Hars B, Hennevin E: Chronic, low-level exposure to the cholinesterase inhibitor DFP. 2. Time course of behavioral state changes in rats. Pharmacol Biochem Behav 1999;64:105-114.
36. Timofeeva O, Gordon C: EEG spectra, behavioural states and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos. Pharmacol Biochem Behav 2002;72:669-679.
37. Inglis F: The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 2002;127:45-63.
38. Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A: Responder characteristics to a single oral dose of cholinesterase inhibitor: A double-blind placebo-controlled study with tacrine in Alzheimer patients. Dement Geriatr Cogn Disord 2001;12:22-32.